Yu Chong Zhang
Direktor/Vorstandsmitglied bei GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD.
Vermögen: 194 Mio $ am 30.04.2024
Aktive Positionen von Yu Chong Zhang
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD. | Direktor/Vorstandsmitglied | 27.12.2019 | - |
Corporate Officer/Principal | 06.12.2018 | - | |
Guangdong Eashu Pharmaceutical Co., Ltd.
Guangdong Eashu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Guangdong Eashu Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of chemical agents, chemical raw materials, and Chinese medicines. It offers medicine in the form of tablets, capsules, and granules. It also provides active pharmaceutical ingredients such as etracaine hydrochloride, carbocisteine, tolbutamide, benzocaine, propafenone hydrochloride, and taurine. The company was founded on October 9, 2000 and is headquartered in Zhaoqing, China. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Yu Chong Zhang
Ausbildung von Yu Chong Zhang
The University of Manchester | Graduate Degree |
Sun Yat-Sen University | Undergraduate Degree |
Statistik
International
China | 4 |
Vereinigtes Königreich | 2 |
Operativ
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Guangdong Eashu Pharmaceutical Co., Ltd.
Guangdong Eashu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Guangdong Eashu Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of chemical agents, chemical raw materials, and Chinese medicines. It offers medicine in the form of tablets, capsules, and granules. It also provides active pharmaceutical ingredients such as etracaine hydrochloride, carbocisteine, tolbutamide, benzocaine, propafenone hydrochloride, and taurine. The company was founded on October 9, 2000 and is headquartered in Zhaoqing, China. | Health Technology |
- Börse
- Insiders
- Yu Chong Zhang
- Erfahrung